Neutralizing gut-derived lipopolysaccharide as a novel therapeutic strategy for severe leptospirosis.

MLA

Xufeng Xie, et al. “Neutralizing Gut-Derived Lipopolysaccharide as a Novel Therapeutic Strategy for Severe Leptospirosis.” ELife, May 2024, pp. 1–23. EBSCOhost, https://doi.org/10.7554/eLife.96065.

APA

Xufeng Xie, Xi Chen, Shilei Zhang, Jiuxi Liu, Wenlong Zhang, & Yongguo Cao. (2024). Neutralizing gut-derived lipopolysaccharide as a novel therapeutic strategy for severe leptospirosis. ELife, 1–23. https://doi.org/10.7554/eLife.96065

Chicago

Xufeng Xie, Xi Chen, Shilei Zhang, Jiuxi Liu, Wenlong Zhang, and Yongguo Cao. 2024. “Neutralizing Gut-Derived Lipopolysaccharide as a Novel Therapeutic Strategy for Severe Leptospirosis.” ELife, May, 1–23. doi:10.7554/eLife.96065.